| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 524 |
| 1 | ACETAMINOPHEN | 431 |
| 2 | ASPIRIN | 416 |
| 3 | OMEPRAZOLE | 416 |
| 4 | ASPIRIN 325 MG | 397 |
| 5 | ASPIRIN 81 MG | 397 |
| 6 | PREDNISONE | 376 |
| 7 | ERGOCALCIFEROL | 368 |
| 8 | METFORMIN | 353 |
| 9 | ADALIMUMAB | 344 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 57 | 0.0165 |
| 1 | TIOPRONIN | 40 | 0.0161 |
| 2 | ERGOCALCIFEROL | 368 | 0.0124 |
| 3 | ONTRUZANT | 6 | 0.0115 |
| 4 | ERYTHROMYCIN ETHYLSUCCINATE | 7 | 0.0114 |
| 5 | PSYLLIUM HUSK | 12 | 0.0089 |
| 6 | ALMOTRIPTAN | 8 | 0.0076 |
| 7 | PERFLUTREN | 38 | 0.0067 |
| 8 | DOXYCYCLINE MONOHYDRATE | 10 | 0.0063 |
| 9 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 7 | 0.0062 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1067 |
| 1 | Corticosteroid [EPC] | 823 |
| 2 | Proton Pump Inhibitor [EPC] | 628 |
| 3 | Benzodiazepine [EPC] | 537 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 444 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 426 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 392 |
| 7 | Provitamin D2 Compound [EPC] | 368 |
| 8 | Vitamin C [EPC] | 363 |
| 9 | GLP-1 Receptor Agonist [EPC] | 359 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 45 | 0.0654 |
| 1 | Urease Inhibitor [EPC] | 1 | 0.0213 |
| 2 | Reducing and Complexing Thiol [EPC] | 40 | 0.0161 |
| 3 | Provitamin D2 Compound [EPC] | 368 | 0.0124 |
| 4 | APOC-III-directed RNA Interaction [EPC] | 1 | 0.0096 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 15 | 0.0072 |
| 6 | Contrast Agent for Ultrasound Imaging [EPC] | 38 | 0.0065 |
| 7 | Small Interfering RNA [EPC] | 1 | 0.0063 |
| 8 | Opioid Antagonist [EPC] | 6 | 0.0062 |
| 9 | Carboxypeptidase [EPC] | 2 | 0.0055 |